Alkaline phosphatase: The next independent predictor of the poor 90-day outcome in alcoholic hepatitis

BioMed Research International

Volumn 2013, Issue , 2013, Pages

  Kasztelan Szczerbinska, Beata ^a   Slomka, Maria ^a   Celinski, Krzysztof ^a   Szczerbinski, Mariusz ^a  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; CORTICOSTEROID;

ADULT; ALCOHOL LIVER DISEASE; ARTICLE; CONTROLLED STUDY; FEMALE; HOSPITAL ADMISSION; HUMAN; LABORATORY; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; PREDICTION; PROGNOSIS; PROSPECTIVE STUDY; RISK FACTOR; SCORING SYSTEM; AGED; BLOOD; METABOLISM; MIDDLE AGED; PATHOLOGY; RECEIVER OPERATING CHARACTERISTIC; SEVERITY OF ILLNESS INDEX; STATISTICAL MODEL; SURVIVAL;

ADRENAL CORTEX HORMONES; ADULT; AGED; ALKALINE PHOSPHATASE; FEMALE; HEPATITIS, ALCOHOLIC; HUMANS; LIVER TRANSPLANTATION; LOGISTIC MODELS; MALE; MIDDLE AGED; PROGNOSIS; RISK FACTORS; ROC CURVE; SEVERITY OF ILLNESS INDEX; SURVIVAL ANALYSIS;

EID: 84885627778     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2013/614081     Document Type: Article

References (40)

1. World Health Organisation, Global Status Raport on Alcohol and Health 2011 2011 Geneva, Switzerland World Health Organisation
2. McCullough A. J., O'Shea R. S., Dasarathy S., Diagnosis and management of alcoholic liver disease. Journal of Digestive Diseases 2011 12 4 257 262 2-s2.0-79960743999 10.1111/j.1751-2980.2010.00470.x
3. O'Shea R. S., Dasarathy S., McCullough A. J., Alcoholic liver disease. Hepatology 2010 51 1 307 328 10.1002/hep.23258
4. Amini M., Runyon B. A., Alcoholic hepatitis 2010: a clinician's guide to diagnosis and therapy. World Journal of Gastroenterology 2010 16 39 4905 4912 2-s2.0-78049493390 10.3748/wjg.v16.i39.4905
5. Forrest E. H., Evans C. D. J., Stewart S., Phillips M., Oo Y. H., McAvoy N. C., Fisher N. C., Singhal S., Brind A., Haydon G., O'Grady J., Day C. P., Hayes P. C., Murray L. S., Morris A. J., Analysis of factors predictive of mortality in alcoholic hepatitis and derivation and validation of the Glasgow alcoholic hepatitis score. Gut 2005 54 8 1174 1179 2-s2.0-22644432242 10.1136/gut.2004.050781 (Pubitemid 41025916)
6. Dunn W., Jamil L. H., Brown L. S., Wiesner R. H., Kim W. R., Menon K. V. N., Malinchoc M., Kamath P. S., Shah V., MELD accurately predicts mortality in patients with alcoholic hepatitis. Hepatology 2005 41 2 353 358 2-s2.0-12844276509 10.1002/hep.20503 (Pubitemid 40165379)
7. Forrest E. H., Morris A. J., Stewart S., Phillips M., Oo Y. H., Fisher N. C., Haydon G., O'Grady J., Day C. P., The Glasgow alcoholic hepatitis score identifies patients who may benefit from corticosteroids. Gut 2007 56 12 1743 1746 2-s2.0-36749037643 10.1136/gut.2006.099226 (Pubitemid 350206302)
8. Srikureja W., Kyulo N. L., Runyon B. A., Hu K. Q., MELD score is a better prognostic model than Child-Turcotte-Pugh score or Discriminant Function score in patients with alcoholic hepatitis. Journal of Hepatology 2005 42 5 700 706 2-s2.0-17044398456 10.1016/j.jhep.2004.12.022
9. Vaa B. E., Asrani S. K., Dunn W., Kamath P. S., Shah V. H., Influence of serum sodium on MELD-based survival prediction in alcoholic hepatitis. Mayo Clinic Proceedings 2011 86 1 37 42 2-s2.0-78650976583 10.4065/mcp.2010.0281
10. Dominguez M., Rincón D., Abraldes J. G., Miquel R., Colmenero J., Bellot P., García-Pagán J. C., Fernández R., Moreno M., Bañares R., Arroyo V., Caballería J., Ginès P., Bataller R., A new scoring system for prognostic stratification of patients with alcoholic hepatitis. American Journal of Gastroenterology 2008 103 11 2747 2756 10.1111/j.1572-0241.2008.02104.x
11. Babor T. F., Higgins-Biddle J. C., Saunders J. B., Monteiro M. G., AUDIT the Alcohol Use Disorders: Identification Test Guidelines for Use in Primary Care 2001 2nd Geneva, Switzerland World Health Organisation
12. Basra G., Basra S., Parupudi S., Symptoms and signs of acute alcoholic hepatitis. World Journal of Hepatology 2011 3 5 118 120
13. Hamid R., Forrest E. H., Is histology required for the diagnosis of alcoholic hepatitis: a review of published randomized controlled trials. Gut 2011 60 article A233 10.1136/gut.2011.239301.492
14. European Association for the Study of the Liver, EASL Clinical Practice Guidelines: management of cholestatic liver diseases. Journal of Hepatology 2009 51 2 237 267 2-s2.0-67649205149 10.1016/j.jhep.2009.04.009
15. Tan H. H., Virmani S., Martin P., Controversies in the management of alcoholic liver disease. Mount Sinai Journal of Medicine 2009 76 5 484 498 2-s2.0-70350719344 10.1002/msj.20135
16. Altamirano J., Fagundes C., Dominguez M., García E., Michelena J., Cárdenas A., Guevara M., Pereira G., Torres-Vigil K., Arroyo V., Caballería J., Ginès P., Bataller R., Acute kidney injury is an early predictor of mortality for patients with alcoholic hepatitis. Clinical Gastroenterology and Hepatology 2012 10 1 65 71 2-s2.0-83855165691 10.1016/j.cgh.2011.09.011
17. Cervoni J. P., Thévenot T., Weil D., Muel E., Barbot O., Sheppard F., Monnet E., Di Martino V., C-reactive protein predicts short-term mortality in patients with cirrhosis. Journal of Hepatology 2012 56 6 1299 1304 10.1016/j.jhep.2011.12.030
18. Garg H., Kumar A., Garg V., Sharma P., Sharma B. C., Sarin S. K., Clinical profile and predictors of mortality in patients of acute-on-chronic liver failure. Digestive and Liver Disease 2012 44 2 166 171 2-s2.0-84855740522 10.1016/j.dld.2011.08.029
19. Papatheodoridis G. V., Cholongitas E., Dimitriadou E., Touloumi G., Sevastianos V., Archimandritis A. J., MELD versus Child-Pugh and creatinine-modified Child-Pugh score for predicting survival in patients with decompensated cirrhosis. World Journal of Gastroenterology 2005 11 20 3099 3104 2-s2.0-20344402339 (Pubitemid 40790670)
20. Martinez M. O., Sayles H., Vivekanandan R., D'Souza S., Florescu M. C., Hepatorenal syndrome: are we missing some prognostic factors? Digestive Diseases and Sciences 2012 57 1 210 214 2-s2.0-84856727091 10.1007/s10620-011-1861-1
21. Huo T. I., Wu J. C., Lin H. C., Lee F. Y., Hou M. C., Lee P. C., Chang F. Y., Lee S. D., Evaluation of the increase in model for end-stage liver disease (ΔMELD) score over time as a prognostic predictor in patients with advanced cirrhosis: risk factor analysis and comparison with initial MELD and Child-Turcotte-Pugh score. Journal of Hepatology 2005 42 6 826 832 2-s2.0-18844375318 10.1016/j.jhep.2005.01.019 (Pubitemid 40693199)
22. Spahr L., Rubbia-Brandt L., Genevay M., Hadengue A., Giostra E., Early liver biopsy, intraparenchymal cholestasis, and prognosis in patients with alcoholic steatohepatitis. BMC Gastroenterology 2011 11 article 115 2-s2.0-80055020944 10.1186/1471-230X-11-115
23. Singal A. K., Kamath P. S., Gores G. J., Shah V. H., Alcoholic hepatitis: current challenges and future directions. Clinical Gastroenterology and Hepatology 2013 10.1016/j.cgh.2013.06.013
24. Bettini R., Gorini M., Effectiveness of ursodeoxycholic acid associated silymarin in the treatment of chronic athrylic hepatopathy. Clinica Terapeutica 2002 153 5 305 307 2-s2.0-0036762491 (Pubitemid 35440024)
25. Pelletier G., Roulot D., Davion T., Masliah C., Causse X., Oberti F., Raabe J. J., Van Lemmens C., Labadie H., Serfaty L., Capron J. P., Levy S., Calè P., Miguet J. P., Beaugrand M. B., Grimbert S., Dao T., Chaput J. C., Naveau S., Cadranel J. F., Chousterman M., Hagège H., Buffet C., Dewailly A., Paris J. C., Raabe J. J., Chapoutot C., Larrey D., Poupon R., Grangé J. D., Pariente A., Morichau-Beauchant M., Audigier C., Coppere H., Ink O., Doffoel M., Larricq J., A randomized controlled trial of ursodeoxycholic acid in patients with alcohol-induced cirrhosis and jaundice. Hepatology 2003 37 4 887 892 2-s2.0-0037382139 10.1053/jhep.2003.50118 (Pubitemid 36397400)
26. Salerno F., Merli M., Cazzaniga M., Valeriano V., Rossi P., Lovaria A., Meregaglia D., Nicolini A., Lubatti L., Riggio O., MELD score is better than Child-Pugh score in predicting 3-month survival of patients undergoing transjugular intrahepatic portosystemic shunt. Journal of Hepatology 2002 36 4 494 500 2-s2.0-0036116345 10.1016/S0168-8278(01)00309-9 (Pubitemid 34407337)
27. Wiesner R., Edwards E., Freeman R., Harper A., Kim R., Kamath P., Kremers W., Lake J., Howard T., Merion R. M., Wolfe R. A., Krom R., Colombani P. M., Cottingham P. C., Dunn S. P., Fung J. J., Hanto D. W., McDiarmid S. V., Rabkin J. M., Teperman L. W., Turcotte J. G., Wegman L. R., Model for end-stage liver disease (MELD) and allocation of donor livers. Gastroenterology 2003 124 1 91 96 2-s2.0-0037223652 10.1053/gast.2003.50016 (Pubitemid 36055342)
28. Angermayr B., Luca A., König F., Bertolini G., Ploner M., Gridelli B., Ulbrich G., Reiberger T., Bosch J., Peck-Radosavljevic M., Aetiology of cirrhosis of the liver has an impact on survival predicted by the Model of End-stage Liver Disease score. European Journal of Clinical Investigation 2009 39 1 65 71 2-s2.0-57649165526 10.1111/j.1365-2362.2008.02063.x
29. Attia K. A., Ackoundou-N'guessan K. C., N'dri-yoman A. T., Mahassadi A. K., Messou E., Bathaix Y. F., Kissi Y. H., Child-Pugh-Turcott versus Meld score for predicting survival in a retrospective cohort of black African cirrhotic patients. World Journal of Gastroenterology 2008 14 2 286 291 2-s2.0-39849100878 10.3748/wjg.14.286 (Pubitemid 351314312)
30. Gotthardt D., Weiss K. H., Baumgärtner M., Zahn A., Stremmel W., Schmidt J., Bruckner T., Sauer P., Limitations of the MELD score in predicting mortality or need for removal from waiting list in patients awaiting liver transplantation. BMC Gastroenterology 2009 9 article 72 2-s2.0-70449359551 10.1186/1471-230X-9-72
31. Lv X. H., Liu H. B., Wang Y., Wang B. Y., Song M., Sun M. J., Validation of model for end-stage liver disease score to serum sodium ratio index as a prognostic predictor in patients with cirrhosis. Journal of Gastroenterology and Hepatology 2009 24 9 1547 1553 2-s2.0-69949190130 10.1111/j.1440-1746.2009.05913.x
32. Biggins S. W., Rodriguez H. J., Bacchetti P., Bass N. M., Roberts J. P., Terrault N. A., Serum sodium predicts mortality in patients listed for liver transplantation. Hepatology 2005 41 1 32 39 2-s2.0-11244299379 10.1002/hep.20517 (Pubitemid 40066380)
33. Kim W. R., Biggins S. W., Kremers W. K., Wiesner R. H., Kamath P. S., Benson J. T., Edwards E., Therneau T. M., Hyponatremia and mortality among patients on the liver-transplant waiting list. New England Journal of Medicine 2008 359 10 1018 1026 2-s2.0-50949127481 10.1056/NEJMoa0801209
34. Yamashiki N., Sugawara Y., Tamura S., Kaneko J., Nojiri K., Aoki T., Sakamoto Y., Hasegawa K., Koike K., Kokudo N., Model for end-stage liver disease and model for end-stage liver disease-na scores predict both before-listing and wait-list mortality. Transplantation Proceedings 2012 44 2 389 392 2-s2.0-84858198829 10.1016/j.transproceed.2012.01.037
35. Angermayr B., Cejna M., Karnel F., Gschwantler M., Koenig F., Pidlich J., Mendel H., Pichler L., Wichlas M., Kreil A., Schmid M., Ferlitsch A., Lipinski E., Brunner H., Lammer J., Ferenci P., Gangl A., Peck-Radosavljevic M., Child-Pugh versus MELD score in predicting survival in patients undergoing transjugular intrahepatic portosystemic shunt. Gut 2003 52 6 879 885 2-s2.0-0038184124 10.1136/gut.52.6.879 (Pubitemid 36613497)
36. Sandahl T. D., Jepsen P., Ott P., Vilstrup H., Validation of prognostic scores for clinical use in patients with alcoholic hepatitis. Scandinavian Journal of Gastroenterology 2011 46 9 1127 1132 2-s2.0-80051714475 10.3109/00365521.2011.587200
37. Sheth M., Riggs M., Patel T., Utility of the Mayo End-Stage Liver Disease (MELD) score in assessing prognosis of patients with alcoholic hepatitis. BMC Gastroenterology 2002 2 article 2 2-s2.0-18744409852 10.1186/1471-230X-2-2 (Pubitemid 38750999)
38. Soultati A. S., Dourakis S. P., Alexopoulou A., Deutsch M., Vasilieva L., Archimandritis A. J., Predicting utility of a model for end stage liver disease in alcoholic liver disease. World Journal of Gastroenterology 2006 12 25 4020 4025 2-s2.0-33746256521 (Pubitemid 44097111)
39. Somsouk M., Kornfield R., Vittinghoff E., Inadomi J. M., Biggins S. W., Moderate ascites identifies patients with low model for end-stage liver disease scores awaiting liver transplantation who have a high mortality risk. Liver Transplantation 2011 17 2 129 136 2-s2.0-79551470420 10.1002/lt.22218
40. Akriviadis E., Botla R., Briggs W., Han S., Reynolds T., Shakil O., Pentoxifylline improves short-term survival in severe acute alcoholic hepatitis: a double-blind, placebo-controlled trial. Gastroenterology 2000 119 6 1637 1648 2-s2.0-0034465251 (Pubitemid 32198689)